Research field (1)：
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (2)：
2020 - 2023 Use of digital PET and deep learning for simultaneous quantification of tumor blood flow and metabolism from FDG PET
2018 - 2021 Development of new therapeutic strategies for hypoxic tumors
Papers (39)：
Satoshi Takeuchi, Kenji Hirata, Keiichi Magota, Shiro Watanabe, Rika Moku, Akihiko Shiiya, Jun Taguchi, Shin Ariga, Tomohiro Goda, Yoshihito Ohhara, et al. Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study. EJNMMI research. 2023. 13. 1. 69-69
Akihiko Shiiya, Takuro Noguchi, Utano Tomaru, Shin Ariga, Yuta Takashima, Yoshihito Ohhara, Jun Taguchi, Satoshi Takeuchi, Yasushi Shimizu, Ichiro Kinoshita, et al. EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment. Cancer science. 2022
Yoshihito Ohhara, Ichiro Kinoshita, Akira Suzuki, Makoto Imagawa, Jun Taguchi, Takuro Noguchi, Satoshi Takeuchi, Yasushi Shimizu, Hideyuki Seki, Junichi Suzuki, et al. Expression of karyopherin alfa 2 and karyopherin beta 1 correlate with poor prognosis in gastric cancer. Oncology. 2022
Yoshitaka Saito, Yoh Takekuma, Takashi Takeshita, Takuro Noguchi, Satoshi Takeuchi, Yasushi Shimizu, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Mitsuru Sugawara. Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin Treatment. Anticancer research. 2022. 42. 7. 3693-3700
Yoshitaka Saito, Yoh Takekuma, Masaki Kobayashi, Naofumi Shinagawa, Takuro Noguchi, Satoshi Takeuchi, Yasushi Shimizu, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Mitsuru Sugawara. Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method. Anticancer research. 2022. 42. 6. 3185-3193
